Changes in hepatic enzyme activities in transgenic mice carrying human prototype c-Ha-ras gene treated with diethylnitrosamine

被引:5
|
作者
Arai, T
Ogawa, T
Nakamura, M
Hosoya, M
Ohnishi, Y
机构
[1] Nippon Vet & Anim Sci Univ, Div Vet Biochem, Musashino, Tokyo 1808602, Japan
[2] Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan
来源
JOURNAL OF VETERINARY MEDICAL SCIENCE | 2002年 / 64卷 / 11期
关键词
aspartate aminotransferase; malate dehydrogenase; transgenic mouse;
D O I
10.1292/jvms.64.1065
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Activities of malate dehydrogenase (MDH) and aspartate aminotransferase in the malate-aspartate shuttle were significantly increased in the cytosolic fractions of livers with early neoplastic symptoms such as swelling and discoloration in transgenic mice carrying the prototype human c-Ha-ras gene, Tg-rasH2 mice, which were administered with diethylnitrosamine (PEN) as a carcinogenic chemical at a dose of 200 mg/kg body weight. Cytosolic MDH/LDH (lactate dehydrogenase) (ML) ratio increased significantly and was considered to be a useful marker to characterize the energy metabolism at early neoplastic stage in livers of the Tg-rasH2 mice.
引用
收藏
页码:1065 / 1067
页数:3
相关论文
共 50 条
  • [1] Skeletal myopathy in Transgenic mice carrying human prototype c-Ha-ras gene
    Tsuchiya, T
    Kobayashi, K
    Sakairi, T
    Goto, K
    Okada, M
    Sano, F
    Sugimoto, J
    Morohashi, T
    Usui, T
    Mutai, M
    TOXICOLOGIC PATHOLOGY, 2002, 30 (04) : 501 - 506
  • [2] Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing
    Yamamoto, S
    Urano, K
    Koizumi, H
    Wakana, S
    Hioki, K
    Mitsumori, K
    Kurokawa, Y
    Hayashi, Y
    Nomura, T
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 : 57 - 69
  • [3] Susceptibility to urethane carcinogenesis of transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) and its modification by butylhydroxytoluene
    Umemura, T
    Kodama, Y
    Hioki, K
    Inoue, T
    Nomura, T
    Kurokawa, Y
    CANCER LETTERS, 1999, 145 (1-2) : 101 - 106
  • [4] Glomerulonephritis with fibrillary deposition in a transgenic mouse carrying the human prototype c-Ha-ras gene (rasH2 mouse)
    Kobayashi, K
    Sano, F
    Mutai, M
    Sugimoto, J
    TOXICOLOGIC PATHOLOGY, 2000, 28 (02) : 359 - 362
  • [5] Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene
    Toyosawa, K
    Tanaka, K
    Imai, T
    Yasuhara, K
    Koujitani, T
    Hirose, M
    Mitsumori, K
    TOXICOLOGIC PATHOLOGY, 2003, 31 (05) : 491 - 495
  • [6] Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors
    Mitsumori, K
    Wakana, S
    Yamamoto, S
    Kodama, Y
    Yasuhara, K
    Nomura, T
    Hayashi, Y
    Maronpot, RR
    MOLECULAR CARCINOGENESIS, 1997, 20 (03) : 298 - 307
  • [7] Histopathological characterization of the skeletal myopathy in rasH2 mice carrying human prototype c-Ha-ras gene
    Tsuchiya, T
    Okada, M
    Sakairi, T
    Sano, F
    Sugimoto, J
    Takagi, S
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2005, 67 (05): : 481 - 489
  • [8] Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing
    Yamamoto, S
    Urano, K
    Nomura, T
    TOXICOLOGY LETTERS, 1998, 103 : 473 - 478
  • [9] Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrying human prototype c-Ha-ras gene and their wild type littermates
    Ohnishi, Y
    Arai, T
    Koshirakawa, M
    Horii, N
    Nakajo, S
    Urano, K
    Usui, T
    Tamaoki, N
    Ueyama, Y
    EXPERIMENTAL ANIMALS, 2001, 50 (01) : 33 - 39
  • [10] Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies
    Mitsumori, K
    Koizumi, H
    Nomura, T
    Yamamoto, S
    TOXICOLOGIC PATHOLOGY, 1998, 26 (04) : 520 - 531